Navigation Links
Germany: Colonoscopy prevents 15,000 cancer cases
Date:3/23/2009

Since 2002, statutory health insurances in Germany have offered an endoscopic examination of the colon (colonoscopy) free of charge for all insured persons from the age of 55. Germany was the first country to make nationwide endoscopic screening for bowel cancer a part of its statutory early cancer detection program.

Scientists headed by Professor Hermann Brenner at DKFZ have now published a first calculation of the number of colorectal cancers prevented between 2003 and 2010 thanks to colonoscopy screening. The results will serve as a decision-making basis for an evidence-based evaluation of the program. Moreover, it is important for each participant to know about the benefits of the examination which is wrongly feared by many as being very unpleasant.

The researchers evaluated all 1.8 million colonoscopies which have been carried out to date in the screening program. As a calculation basis they used the number of discovered and removed advanced precancerous lesions (adenomas) which are highly likely to progress into cancer. The epidemiologists have estimated that participation in screening colonoscopy will prevent about 15,000 cases of colorectal cancer by the year 2010.

About 73.000 new cases of colorectal cancer are diagnosed each year in Germany. Around 40 percent of patients die within five years after diagnosis and another portion of sufferers succumb to the disease in the course of the following years. Therefore, Brenner's research team expects that the colonoscopy program will save around 7,500 lives between the years of 2003 and 2010 thanks to the removal of precancerous lesions alone. Moreover, since colonoscopy examinations detect cancer usually at an early stage when it is still curable, the screening program will prevent even more deaths.

The results obtained are based on complex calculations: The number of advanced adenomas found must calculated against the probability that these cancer precursors turn into cancer within a particular period of time. In addition, the calculation takes account of other factors such as the percentage of screening participants who die of other causes before cancer occurs and the participation rate in the respective age groups.

The investigators calculated the number of cancer cases prevented for each year individually and accumulated the values. Although the number of advanced adenomas discovered remains nearly constant over the years, the rate of cancer cases prevented rises each year, since many of the adenomas discovered and removed would otherwise have become cancerous several years later.

The yearly participation rate in colonoscopy screening has remained almost constant since 2003 at about four percent of eligible women and three percent of eligible men. Participants with inconspicuous examination results are offered a second examination free of charge after ten years. Thus, the total participation rate among those under 70, projected to the ten years between first and second screening colonoscopy, is 40 percent among women and 30 percent among men. "This is not bad for a beginning," says Hermann Brenner, "but if we succeeded in encouraging even more people to participate in the screening program such as by sending personal invitations to examinations due many more cancers could be prevented."


'/>"/>

Contact: Dr. Sibylle Kohlstaedt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Related medicine news :

1. What to Expect From a Colonoscopy
2. Water method for unsedated colonoscopy; interval between prep and colonoscopy predicts prep quality
3. Free Video for Health Care Providers and Patients Who are Preparing for a Colonoscopy Is Now Available at www.TriLyte.com
4. Katie Couric Misrepresented Screening Benefits - Claims Death By Colonoscopy Expose
5. Colonoscopy Quality Critical Factor to Thorough Exam and Best Colon Cancer Detection
6. Annals colonoscopy study underscores importance of quality standards
7. ASGE urges patients to seek a qualified endoscopist before undergoing a colonoscopy
8. Colonoscopy Has a Right Side Blind Spot
9. Narrow-band imaging comparable to white light colonoscopy in differentiating colorectal polyps
10. Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product
11. Risk of colorectal cancer extremely low 5 years after a normal colonoscopy screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... Clearwater, Fla. (PRWEB) , ... March 27, 2017 , ... ... (1) and the number of homeowners utilizing DIY and unlicensed contractors for renovations is ... bathroom remodel or replacement project in 2015, and of those, 42% failed to use ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition of ... This acquisition will add four additional processing facilities and a vast array of ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017 On Friday, ... NASDAQ Composite closed the trading session up 0.19%; the ... S&P 500 was down 0.08%. US markets made broad ... the day in green. Pre-market today, Stock-Callers.com reviews these ... N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group ...
(Date:3/27/2017)... March 27, 2017  Twist Bioscience, a company accelerating ... announced that it raised an additional $33 million. To ... million. "It is an exciting time ... reach and continue to deliver industry-leading gene volume to ... commented Emily M. Leproust, Ph.D., CEO of Twist Bioscience. ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. ... for life-threatening inherited liver diseases in children, today ... full year ended December 31, 2016 and provided ... "PhaseRx continued to make progress during the ... positive results from our non-human primate safety study, and ...
Breaking Medicine Technology: